Barry Kreiswirth, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI) (IMAGE)

Hackensack Meridian Health

Barry Kreiswirth, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI)

Caption

Barry Kreiswirth, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI), in front of a surveillance map. Kreiswirth and colleagues at Quest Diagnostics are assessing the nationwide implications of drug-resistant strains of Klebsiella pneumoniae. Their latest work is in Nature Communications.

Credit

Hackensack Meridian Health

Usage Restrictions

Usage with permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.